This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Duke University, The University of North Carolina at Chapel Hill. Active years: 2021.
Company Filing History:
1 out of 2,075 
1 out of 1,325 
Years Active: 2021
Title: Danyu Lin: Innovator in Vascular Health
Introduction
Danyu Lin is a prominent inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of vascular health through his innovative research and patents. His work focuses on identifying risks associated with vascular endothelial growth factor (VEGF) pathway inhibitors.
Latest Patents
Danyu Lin holds a patent titled "Methods of identifying risk of vascular endothelial growth factor (VEGF) pathway inhibitor-induced hypertension." This patent relates to methods for identifying subjects at risk of developing toxicities, such as proteinuria and hypertension, due to the administration of bevacizumab. The methods involve measuring nucleic acid or gene mutations in samples obtained from the subjects, showcasing Lin's commitment to advancing medical science.
Career Highlights
Throughout his career, Danyu Lin has worked at esteemed institutions, including the University of North Carolina at Chapel Hill and Duke University. His experience in these research environments has allowed him to collaborate with leading experts in the field and contribute to groundbreaking studies.
Collaborations
Some of Danyu Lin's notable coworkers include Kouros Owzar and Jin Wang. Their collaborative efforts have further enhanced the impact of Lin's research and innovations in the medical community.
Conclusion
Danyu Lin is a dedicated inventor whose work in identifying risks associated with VEGF pathway inhibitors has the potential to improve patient outcomes in vascular health. His contributions to the field are invaluable and reflect his commitment to advancing medical research.